Highlights Anatara Lifesciences Ltd

Equities

ANR

AU000000ANR0

Market Closed - Australian S.E. Other stock markets 00:06:23 2024-05-10 EDT			5-day change	1st Jan Change
0.041 ^AUD	-4.65%		-14.58%	+86.36%

05-01	Anatara Lifesciences Raises AU$1 Million via Shares Placement; Shares Decline 6%	MT
04-09	Anatara Lifesciences Begins Recruitment for Irritable Bowel Syndrome Stage Two Trial	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Anatara Lifesciences Raises AU$1 Million via Shares Placement; Shares Decline 6%	04-30	MT
Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2023	02-27	CI
Anatara Lifesciences Ltd Reports Earnings Results for the Full Year Ended June 30, 2023	23-08-23	CI
Anatara Lifesciences Receives R&D Tax Rebate; Shares Up 3%	23-08-14	MT
Anatara Lifesciences Provides Update on the Gastrointestinal Reprogramming(Garp) Trial for IBS	23-03-09	CI
Anatara Lifesciences Ltd Reports Earnings Results for the Half Year Ended December 31, 2022	23-02-23	CI
Anatara Lifesciences Receives More than $310,000 R&D Tax Rebate	22-10-04	MT
Anatara Lifesciences Limited Provides Updates on 3FDC Clinical Trial	22-10-02	CI
Anatara Lifesciences Limited Reports Earnings Results for the Full Year Ended June 30, 2022	22-08-29	CI
Anatara Lifesciences Limited Announces to Provide an Update on the Progress of Clinical Trials in Irritable Bowel Syndrome and Psychological Functioning	22-06-21	CI
Anatara Lifesciences Updates on Progress of Clinical Trials in Psychological Functioning and Irritable Bowel Syndrome, Diarrhoea Subtype	22-05-19	CI
Anatara Lifesciences Provides Clinical Trials Update	22-03-30	CI
Anatara Lifesciences Limited Reports Earnings Results for the Half Year Ended December 31, 2021	22-02-23	CI
Anatara Lifesciences Limited Provides Clinical Trials Update on Progress of Clinical Trials in Psychological Functioning and Irritable Bowel Syndrome, Diarrhoea Subtype	22-02-16	CI
Anatara Lifesciences Limited Provides Update on Progress of Clinical Trials in Psychological Functioning and Irritable Bowel Syndrome	21-12-15	CI
ObvioHealth Partners with Anatara Lifesciences to Launch First-Of-Its-Kind Decentralized Clinical Trial in Australia	21-09-30	CI
Anatara Lifesciences Limited Reports Earnings Results for the Full Year Ended June 30, 2021	21-08-23	CI
Anatara Lifesciences Limited Announces Successful Piglet Study	21-08-05	CI
Anatara Lifesciences : Progresses Planned Human Clinical Trials for Gastrointestinal Medicines	21-05-31	MT
Anatara Lifesciences Provides This Update on Clinical Trial Activities	21-05-30	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Anatara Lifesciences Ltd

Equities

ANR

AU000000ANR0

Highlights

Filters